Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Intangibles: 2013-2024

Historic Intangibles for Amphastar Pharmaceuticals (AMPH) over the last 7 years, with Dec 2024 value amounting to $29.2 million.

  • Amphastar Pharmaceuticals' Intangibles changed negligibly% to $29.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $29.2 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $29.2 million for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Intangibles of $29.2 million as of FY2024, which was down 0.00% from $29.2 million recorded in FY2023.
  • Amphastar Pharmaceuticals' Intangibles' 5-year high stood at $29.2 million during FY2020, with a 5-year trough of $29.2 million in FY2020.
  • In the last 3 years, Amphastar Pharmaceuticals' Intangibles had a median value of $29.2 million in 2024 and averaged $29.2 million.